Medtronic Spine and Biologics Revenue and Competitors
Estimated Revenue & Valuation
- Medtronic Spine and Biologics's estimated annual revenue is currently $90.4M per year.
- Medtronic Spine and Biologics's estimated revenue per employee is $251,000
Employee Data
- Medtronic Spine and Biologics has 360 Employees.
- Medtronic Spine and Biologics grew their employee count by -1% last year.
Medtronic Spine and Biologics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director Product Development | Reveal Email/Phone |
2 | Engineering Manager | Reveal Email/Phone |
3 | Senior Case Specialist | Reveal Email/Phone |
4 | Training & Education Specialist- Mazor | Reveal Email/Phone |
5 | Sales Consultant | Reveal Email/Phone |
6 | Sales Rep II, Interventional Therapies | Reveal Email/Phone |
7 | Sr. Director Sales Operations | Reveal Email/Phone |
8 | Principal R&D Engineer | Reveal Email/Phone |
9 | Senior Sales Representative | Reveal Email/Phone |
10 | Sr. Supervisor | Reveal Email/Phone |
Medtronic Spine and Biologics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Medtronic Spine and Biologics?
N/A
Total Funding
360
Number of Employees
$90.4M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Medtronic Spine and Biologics News
2022-04-20 - Medtronic names new chief scientific, medical, and regulatory ...
Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator...
2022-04-06 - Could Medtronic's spine business be the next medtech spinoff?
"Given [Medtronic's] limited exposure to orthopedics outside of spine, we believe management might choose to spin off the spine business (...
2022-03-30 - Analysts see Medtronic's diabetes, spine businesses as most ...
Needham analysts published a report singling out the diabetes and spine businesses as possible spinoff options for Medtronic (NYSE:MDT).
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 360 | 6% | N/A |
#2 | $15M | 360 | 20% | N/A |
#3 | $35M | 360 | 0% | N/A |
#4 | $35M | 360 | 8% | N/A |
#5 | $35M | 360 | 6% | N/A |